(Q38397177)

2 September 2017

1 reference

title

Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

2 September 2017

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

M Pallayova

1

1 reference

2 September 2017

S Taheri

series ordinal

2

1 reference

2 September 2017

publication date

28 July 2014

1 reference

2 September 2017

1 reference

2 September 2017

volume

4

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

243-253

1 reference

Nonalcoholic fatty liver disease

2 September 2017

cites work

1 reference

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

21 January 2018

1 reference

HCC and NASH: how strong is the clinical demonstration?

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

The epidemiology of nonalcoholic fatty liver disease: a global perspective

21 January 2018

1 reference

Nonalcoholic fatty liver disease as a complication of insulin resistance

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides

21 January 2018

1 reference

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

21 January 2018

1 reference

Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis

21 January 2018

1 reference

A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease

21 January 2018

1 reference

Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

21 January 2018

1 reference

Non-alcoholic fatty liver disease in common endocrine disorders

21 January 2018

1 reference

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease and low-carbohydrate diets

21 January 2018

1 reference

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

The role of the lipogenic pathway in the development of hepatic steatosis.

21 January 2018

1 reference

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

21 January 2018

1 reference

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

21 January 2018

1 reference

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis

21 January 2018

1 reference

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease

21 January 2018

1 reference

Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies

21 January 2018

1 reference

The gut microbiota and the liver. Pathophysiological and clinical implications.

21 January 2018

1 reference

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

21 January 2018

1 reference

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study

21 January 2018

1 reference

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

21 January 2018

1 reference

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

21 January 2018

1 reference

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

21 January 2018

1 reference

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes

21 January 2018

1 reference

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

21 January 2018

1 reference

Nonalcoholic fatty liver disease and atherosclerosis

21 January 2018

1 reference

Relation of hepatic steatosis to atherogenic dyslipidemia

21 January 2018

1 reference

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

21 January 2018

1 reference

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

21 January 2018

1 reference

Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans

21 January 2018

1 reference

Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.

21 January 2018

1 reference

Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis

21 January 2018

1 reference

Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006.

21 January 2018

1 reference

Nonalcoholic steatohepatitis and increased risk of chronic kidney disease

21 January 2018

1 reference

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

21 January 2018

1 reference

Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.

21 January 2018

1 reference

Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease

21 January 2018

1 reference

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

21 January 2018

1 reference

Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?

21 January 2018

1 reference

Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994

21 January 2018

1 reference

Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study

21 January 2018

1 reference

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.

21 January 2018

1 reference

Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Imaging-based quantification of hepatic fat: methods and clinical applications

21 January 2018

1 reference

Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods.

21 January 2018

1 reference

Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy

21 January 2018

1 reference

Clinical aspects of fatty liver disease

21 January 2018

1 reference

How to approach endocrine assessment in severe obesity?

21 January 2018

1 reference

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography

21 January 2018

1 reference

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

21 January 2018

1 reference

Noninvasive tools to assess hepatic fibrosis: ready for prime time?

21 January 2018

1 reference

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids

21 January 2018

1 reference

Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial

21 January 2018

1 reference

Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism.

21 January 2018

1 reference

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

21 January 2018

1 reference

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

21 January 2018

1 reference

Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Dietary composition and nonalcoholic fatty liver disease

21 January 2018

1 reference

The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

21 January 2018

1 reference

Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction

21 January 2018

1 reference

Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease

21 January 2018

1 reference

Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men.

21 January 2018

1 reference

Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease

21 January 2018

1 reference

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients.

21 January 2018

1 reference

Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects

21 January 2018

1 reference

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

21 January 2018

1 reference

Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults

21 January 2018

1 reference

Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes

21 January 2018

1 reference

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

Evaluation of lorcaserin for the treatment of obesity

21 January 2018

1 reference

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

21 January 2018

1 reference

Statins and hepatotoxicity: focus on patients with fatty liver

21 January 2018

1 reference

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

21 January 2018

1 reference

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

21 January 2018

1 reference

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.

21 January 2018

1 reference

A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome

21 January 2018

1 reference

Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease

21 January 2018

1 reference

Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet

21 January 2018

1 reference

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study

21 January 2018

1 reference

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial

21 January 2018

1 reference

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis

21 January 2018

1 reference

Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists

21 January 2018

1 reference

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Nonalcoholic fatty liver disease and bariatric surgery

21 January 2018

1 reference

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

21 January 2018

1 reference

Bariatric surgery for non-alcoholic steatohepatitis in obese patients

21 January 2018

1 reference

Evolving aspects of liver transplantation for nonalcoholic steatohepatitis

21 January 2018

1 reference

Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease

21 January 2018

1 reference

Therapeutic potential of fecal microbiota transplantation

21 January 2018

1 reference

Resveratrol in metabolic health: an overview of the current evidence and perspectives.

21 January 2018

1 reference

Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis

21 January 2018

1 reference

Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/COB.12068

1 reference

2 September 2017

1 reference